Tag: Preliminary

OpGen Announces Preliminary Unaudited Profits for Fiscal 2020 and Delivers Company Update

Preliminary overall pro-forma put together earnings for 2020 was around $5.2 million Maintained solid balance sheet with $13.3 million hard cash as of December 31, 2020 and full funds elevated in 2020 of $35.3 million OpGen subsidiary Ares Genetics to investigate numerous collaboration opportunities with numerous get-togethers GAITHERSBURG, Md., Jan. 13, 2021 — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision… Read more →